Pharmaceuticals in Brazil

Publication Date	January 2008
Publisher	Datamonitor
Product Type	Report
Pages	34
ISBN Number	not applicable
Product Code	DAT03046

Price

£125.00
approximately: $234 | €159

PDF

Order above formats by FAX

Summary

Datamonitor's Pharmaceuticals in Brazil industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of the industry's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of the industry
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by value and/or volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Market shares are covered by manufacturer or brand

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange v the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.

Content

Executive Summary
Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
Chapter 2 Market Value
Chapter 3 Market Segmentation I
Chapter 4 Market Segmentation Ii
Chapter 5 Market Share
Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
Chapter 7 Leading Companies
- 7.1 Glaxosmithkline Plc
- 7.2 Novartis Ag
- 7.3 Ems Sigma Pharma
- 7.4 Pfizer Inc
Chapter 8 Market Forecasts
- 8.1 Market Value Forecast
Chapter 9 Macroeconomic Indicators
Chapter 10 Appendix
- 10.1 Methodology
- 10.2 Industry Associations
- 10.3 Related Datamonitor Research
List Of Tables
- Table 1: Brazil Pharmaceuticals Market Value: $ Million, 2003-2007
- Table 2: Brazil Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: Brazil Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: Brazil Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Glaxosmithkline Plc
- Table 6: Key Financials: Glaxosmithkline Plc
- Table 7: Key Facts: Novartis Ag
- Table 8: Key Financials: Novartis Ag
- Table 9: Key Facts: Ems Sigma Pharma
- Table 10: Key Facts: Pfizer Inc
- Table 11: Key Financials: Pfizer Inc
- Table 12: Brazil Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
- Table 13: Brazil Size Of Population (Million) , 2003-2007
- Table 14: Brazil Gdp (Constant 2000 Prices, $ Billion), 2003-2007
- Table 15: Brazil Inflation, 2003-2007
- Table 16: Brazil Exchange Rate, 2003